Am J Physiol Endocrinol Metab. 2016;311(1):E56-68.
27143556
https://corcept.com/wp-content/uploads/COR-logo.svg00imc@healthandcommerce.comhttps://corcept.com/wp-content/uploads/COR-logo.svgimc@healthandcommerce.com2018-09-19 00:00:002018-09-19 00:00:00Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
